Europe Colonoscopes Market Developments and Forecast by 2028

The Europe colonoscopes market is expected to reach US$ 559.16 million by 2028 from US$ 419.41 million in 2021; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028.   

A few factors such as the increasing prevalence of colorectal cancer, growing research activities to extend its applications in therapeutic areas, technological advancements in colonoscopy devices, and development of robotic colonoscopes are driving the growth of the colonoscope market. However, the availability of alternative diagnostic tests for rectal diseases hampers the market growth.

The success rate of diagnosing colorectal conditions, including cancer, has increased with advancements in technologies. Flexible endoscopy is an effective method enabling the early diagnosis and treatment of gastrointestinal cancer, making it a popular choice for screening. However, a large population that benefits from endoscopic colorectal cancer screening feels skeptical about undergoing the procedure. This is mainly ascribed to psychological barriers due to the indignity of the process, fear of procedure-related pain, discomfort in bowel preparation, and potential need for sedation, which underlines an urgent need for new technologies for addressing these issues. To significantly reduce the adenoma “miss rate” of standard forward-viewing colonoscopy, manufacturers are continuously striving to improve the current colonoscopy techniques, by exploring more advanced optics and wider-angle visualization tools along with a user-friendly, intuitive endoscopic platform interface. The introduction of such technologies is fueling the colonoscope market growth. Also, March is marked as the National Colorectal Awareness Month, dedicated to encouraging patients, survivors, and caregivers to share their stories, advocate for colorectal cancer prevention, and inform others about the importance of early detection. Thus, growing awareness about the effect of colon disorders will increase the adoption of colonoscopy tests during the forecast period, thus offering lucrative opportunities to the market players.

Europe has been hit hard by an exponential increase in the number of COVID-19 cases and deaths, leading to congestion in the plumbing system and high infection rates among health professionals. The rising rate of confirmed cases is putting an increased burden on the region's healthcare system, which is propelling the demand for diagnostic tests in their healthcare system and supporting the expansion of the sector in the region. The colonoscope market suffered from a shortage at the beginning of the COVID-19 crisis due to the disruption in the supply chain and reduced demand due to the lockdown announced by most European countries. Market participants and end-users are losing their businesses due to the temporary closure of industries in various countries. The COVID-19 pandemic has hereby exposed the weaknesses and lack of resilience in European health systems, with severe consequences for cancer care and patients. Crucial attention is required to restore cancer care, and prepare for the challenges ahead like risk stratification, i.e., prioritizing cancer patients at higher risk according to cancer type, tumor type, or tumor stage. For instance, using fecal immunochemical tests (FIT) to identify patients at highest risk for developing colorectal cancer (CRC) and refer them to urgent colonoscopy to manage the reduced colonoscopy capacity best while ensuring rapid diagnosis and treatment of CRC. Based on the opinion of the European Society of Gastrointestinal Endoscopy and Endoscopy Nurse and Associates (ESGE-ESGENA), colonoscopies for colorectal cancer screening (CRCS) have been guaranteed at most referral centers and have been labeled as “high priority endoscopy procedures” in Europe.

EUROPE COLONOSCOPES MARKET SEGMENTATION

By Product Type

• Fiber Optic Colonoscopy Devices
• Video Colonoscopy Devices

By Application

• Colorectal Cancer
• Lynch Syndrome
• Ulcerative Colitis
• Crohn's Disease
• Polyp

By End User

• Hospitals
• Ambulatory Surgery Center
• Other End Users

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• Fujifilm Corporation
• Olympus Corporation
• KARL STORZ SE & Co. KG
• EndoMed Systems
• PENTAX Medical
• Boston Scientific Corporation
• Ambu A/S
• SonoScape Medical Corp.

Europe Colonoscopes Report Scope